BiotechTubeBiotechTube
Home/DiaSorin/Fabio Perversi
FP

Fabio Perversi

Chief Human Resources Officer (CHRO)

DiaSorin

Therapeutic Areas

Infectious DiseasesEndocrinologyGastroenterologyAutoimmune DiseasesOncologyCardiovascularMetabolic Disorders

DiaSorin Pipeline

DrugIndicationPhase
LIAISON® QuantiFERON® TB-Gold PlusTuberculosis infection detectionApproved/Commercial
LIAISON® MeMed BV®Differentiation of bacterial vs. viral infectionsApproved/Commercial
LIAISON® CalprotectinInflammatory Bowel Disease (IBD) diagnosis & monitoringApproved/Commercial
MUREX Anti-HDVHepatitis D Virus (HDV) detectionApproved/Commercial
LIAISON® XL SystemImmunoassay testing platformCommercial
LIAISON® XS SystemImmunoassay testing platformCommercial
Luminex xMAP® TechnologyMultiplex testing for infectious disease, geneticsCommercial

Leadership Team at DiaSorin

CR
Carlo Rosa
Chief Executive Officer (CEO)
PP
Piergiorgio Pedron
Chief Financial Officer (CFO)
MB
Marco Baccanti
Head of Corporate Development & Strategy
DB
Daniele Bencini
Chief Operating Officer (COO) - Operations
FR
Francesco Raimondo
Chief Operating Officer (COO) - Commercial
RV
Rosella Visconti
Chief Quality & Regulatory Affairs Officer
GS
Gianluca Sibilia
Chief Information Officer (CIO)
View full DiaSorin profile